The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Rajan Patel, MD: Breaking New Ground in Minimally Invasive CV Care
Progress in invasive measures for cardiovascular conditions has allowed clinicians the ability to venture into new ground.
Khaldoun Tarakji, MD, MPH: Assessing, Advancing the WRAP-IT Results
What plans are held to progress the impressive findings of an envelope for cardiovascular device infection?
Adam DeVore, MD: Sacubitril/Valsartan Benefits in PIONEER-HF Extension
An extension of the study showed sacubitril/valsartan's benefit as an initial hospitalized heart failure therapy.
E-Cigarette Use Linked to Increased Stroke, Coronary Artery Disease
Observed data from a 96,000-plus participant survey found the popularized cigarette alternative is also associated with a greater risk of depression.
Wouter Jukema, MD, PhD: ODYSSEY OUTCOMES in Post-Acute Coronary Syndrome
How alirocumab fared for patients with polyvascular disease in a subset of the major clinical trial.
Malissa J. Wood, MD: Improving Women's Cardiovascular Diagnoses and Care
Heart disease is the greatest cause of death in women, and Wood believes female patients would better from a multidisciplinary approach.
Empagliflozin Reduces Heart Failure Re-Hospitalization, Mortality
Among participants of the EMPA-REG OUTCOME trial who experienced heart failure, empagliflozin was associated with lower rates of short-term re-hospitalization and death.
Khaldoun Tarakji, MD, MPH: WRAP-IT Results
How an antibiotic envelope can address concerns of infection in cardiovascular devices.
Remote Blood Pressure Monitoring Linked to Improved Patient Control
A new study of a blood pressure-monitoring mobile app reports patients with diabetes could reach better thresholds.
Michael J. Reardon, MD: The TAVR Study for Low-Risk Mortality
What do some of the findings from one of the biggest presentations at ACC mean for the state of valve replacement care?
Douglas Drachman, MD: Learning Through Cardiovascular Crises
Why every care provider must be able to prepare for and commit to an "emergency protocol" in the face of adversity.
Study: Pregnant Women Rarely Screened for Hyperlipidemia
A 5000-plus patient study found that about 80% of young women have never been administered a lipid test.
Young Adult Heart Attacks on the Rise in the US
The rate of heart attacks among patients under 40 years old has been increasing by 2% annually for the past decade.
ACC, AHA Present New Cardiovascular Prevention Guideline
New recommendations for prevention focus on risk factors, new therapies, and press against the popular use of aspirin as a preventive therapy.
Diabetes Amputation Risk Not Worsened by SGLT-2 Inhibitors
A 3 million-plus patient longitudinal study found the drug class was no worse for amputation risks than other diabetes therapies, despite recent conflicting studies.
Steve Nissen, MD: The Next Generation of SGLT-2 Trials
Now that SGLT-2 inhibitors have reached the market, how will clinicians compare their benefits in patients?
Jason H. Wasfy, MD: Optimal Inpatient, Outpatient Heart Care
How is telehealth already influencing how some hospitals manage cardiovascular concerns?
Midwest Hospital Infective Endocarditis Rates Spiked During Opioid Crisis
Admissions for infective endocarditis related to intravenous drug use increased 436% from 2012-2017 at an Ohio medical center.
Jose Tafur, MD: Managing Patient Goals Through Stent Therapy
How advancing stent therapy options have come to bridge the gap between improving and elongating a patient's life.
Steve Nissen, MD: SGLT-2 Inhibitors, Then & Now
How the effective cardiovascular drug class have reach a state of impending head-to-head trials.
Jason H. Wasfy, MD: The Limitation of Cardiovascular Readmission Penalties
A system which rewards hospitals based on their patient readmission rates may not be considering other factors of care.
Dapagliflozin Improves Measures of Left Ventricular Function in T2DM Patients
A prospective study found that daily dapagliflozin significantly improved mitral flow, left ventricular mass index, and left atrial volume index after 6 months of treatment.
Rivaroxaban Significantly Benefits Stroke Prevention in Real-World Setting
The Janssen therapy was significantly more beneficial for atrial fibrillation patients than warfarin.
Increased Air Pollution, Arterial Inflammation Linked to MACE
A new study reports an independent association between air pollution and arterial inflammation—and that the former could serve as a predictor to events like stroke and myocardial infarction.
Gregg C. Fonarow, MD: Comparing, Advancing SGLT-2 Inhibitors
No head-to-head trials exist for the inhibitors, but current data shows consistency across the board for each drug.
ACC Updates Guidelines for Treating Patients with Atrial Fibrillation
The ACC, in conjunction with the AHA and Heart Rhythm Association, released their 2019 guideline for the management of patients with atrial fibrillation.
Neal Walker, MD: Investigating a Topical Treatment for Warts
There are currently no FDA-approved prescription treatments for common warts, instead dermatologists must rely on painful alternatives like cutting, burning, and freezing.
Patrick Burnett, MD, PhD: Pipeline Progress of VP-102 for Molluscum Contagiosum
Following the completion of 2 pivotal trials, a new drug application for VP-102 will be submitted later this year.
Gregg C. Fonarow, MD: Improving Heart Failure Care
Recently new therapy options are becoming more evidenced by the day. But have they reached their fullest potential?
Simon Murray, MD: Diagnosis and Treatment of Onychomycosis
Onychomycosis—fungal infection of the nail—is a common medical problem. Treatments are widely available, but relapse is common.